Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis

Med Oncol. 1996 Mar;13(1):31-42. doi: 10.1007/BF02988839.

Abstract

Plasma obtained from lethally irradiated animals contains a megakaryocyte (MK) growth factor which has recently been identified as the ligand for the c-mpl receptor and has been named thrombopoietin (TPO). We demonstrate that post-irradiation aplastic canine plasma (PICS-J) and plasma from a human subject (ML) who was accidentally exposed to lethal irradiation, contain high levels of this activity, which support both MK proliferation and maturation in a dose-dependent manner. These plasma were far more active in stimulating human MK colony formation than other types of thrombocytopenic plasma or a number of exogenously added human recombinant cytokines and their combinations. The addition of stem cell factor (SCF), which alone has a minimal stimulatory affect, to post lethal-irradiation plasma provided a synergistic stimulation of megakaryocytopoiesis both in colony assays and liquid cultures. In colony assays, the combination of SCF with PICS-J or ML almost doubled the number of burst forming units (BFU-MK) and provided a 1.5-fold increase in colony forming units (CFU-MK). A 1.6-fold increase in the number of CD34+ BM cell-derived MK colonies was also elicited. In liquid cultures, the presence of both SCF and PICS-J or ML induced the appearance of a high proportion of CD34+ (6.56% vs 0.6% control) and CD41+ (3.5% vs 1.2% control) cells after 3 days in culture. By day 10, 66.8 x 10(4) CD41+ cells and 29.8 x 10(4) CD34+ cells were derived from 2 x 10(6) BMMC originally seeded. We propose that these unique plasma, which do not contain elevated level of IL-6, IL-3, GM-CSF, IL-1 beta, erythropoietin or SCF, probably contain high levels of TPO. The addition of SCF to the post-irradiation plasma provides a synergistic stimulation of megakaryocytopoiesis which may become relevant for future clinical application.

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anemia, Aplastic / blood
  • Anemia, Aplastic / drug therapy
  • Anemia, Aplastic / etiology
  • Animals
  • Blood Proteins / pharmacology*
  • Bone Marrow Transplantation
  • Cell Division / drug effects
  • Cells, Cultured
  • Colony-Stimulating Factors / pharmacology*
  • Dogs
  • Drug Synergism
  • GPI-Linked Proteins
  • Hematopoiesis / drug effects*
  • Hematopoiesis / radiation effects
  • Humans
  • Male
  • Megakaryocytes / drug effects*
  • Megakaryocytes / radiation effects
  • Membrane Glycoproteins
  • Mesothelin
  • Proteins / pharmacology*
  • Radiation Injuries, Experimental
  • Radioactive Hazard Release
  • Stem Cell Factor / pharmacology*
  • Whole-Body Irradiation / adverse effects

Substances

  • Blood Proteins
  • Colony-Stimulating Factors
  • GPI-Linked Proteins
  • Membrane Glycoproteins
  • Proteins
  • Stem Cell Factor
  • Mesothelin